Large gap with delayed quotes
|
Last quote
12/05/2025
-
02:00:00
|
Bid
12/05/2025 -
10:09:44
|
Bid Volume |
Ask
12/05/2025 -
10:09:44
|
Ask Volume |
|---|---|---|---|---|
|
63.54
-0.28
(
-0.44% )
|
53.88
|
100 |
86.84
|
100 |
Analysis date: 02.12.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 02.12.2025.
Interest
Strong
Strong
Three stars since 28.11.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 07.10.2025 at a price of 59.19.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 21.11.2025.
4wk Rel Perf
0.90%
0.90%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
High
High
The stock has been on the high-sensitivity level since 02.12.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.41%.
Mkt Cap in $bn
9.93
9.93
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.74
0.74
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
25.24
25.24
The estimated PE is for the year 2028.
LT Growth
18.21%
18.21%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.51%
0.51%
The twelve month estimated dividend yield represents 12.83% of earnings forecasts.
Beta
99
99
For 1% of index variation, the stock varies on average by 0.99%.
Correlation
0.47
0.47
47.09% of stock movements are explained by index variations.
Value at Risk
24.05
24.05
The value at risk is estimated at USD 24.05. The risk is therefore 38.20%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004